Free Trial

Eton Pharmaceuticals (ETON) SEC Filings & 10K Form

Eton Pharmaceuticals logo
$10.02 -0.44 (-4.21%)
(As of 11/15/2024 ET)

Recent Eton Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/07/2024
6:05 AM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
3:05 PM
Eton Pharmaceuticals (Issuer)
Opaleye Management Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
5:34 PM
Eton Pharmaceuticals (Issuer)
Opaleye Management Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:19 PM
Eton Pharmaceuticals (Issuer)
Krempa David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
5:30 AM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
6:31 PM
Eton Pharmaceuticals (Issuer)
Opaleye Management Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:05 PM
Eton Pharmaceuticals (Issuer)
Opaleye Management Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
3:05 PM
Eton Pharmaceuticals (Subject)
Opaleye Management Inc. (Filed by)
Form SC 13G/A
08/08/2024
3:25 PM
Eton Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2024
3:16 PM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
3:16 PM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:17 PM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:25 PM
Eton Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2024
6:15 AM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
6:00 AM
Eton Pharmaceuticals (Subject)
HARROW, INC. (Filed by)
HARROW, INC. (Filed by)
HARROW, INC. (Filed by)
Form SC 13D/A
04/26/2024
3:21 PM
Eton Pharmaceuticals (Filer)
Form DEF 14A
04/18/2024
3:22 PM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
3:24 PM
Eton Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/22/2024
5:55 AM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
5:55 AM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
3:15 PM
Eton Pharmaceuticals (Issuer)
RIEDEL NORBERT G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:16 PM
Eton Pharmaceuticals (Issuer)
MAIER PAUL V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:17 PM
Eton Pharmaceuticals (Issuer)
Krempa David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:18 PM
CASAMENTO CHARLES J (Reporting)
Eton Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:19 PM
BRYNJELSEN SEAN (Reporting)
Eton Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:19 PM
Adams Jennifer McKie (Reporting)
Eton Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:21 PM
Eton Pharmaceuticals (Issuer)
Gruber James R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
5:55 AM
Eton Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ETON) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners